Saturday, July 31, 2010

V5 Update and Development

January 8, 2010 by ian  
Filed under Fitech News

It’s been an extremely hectic year for Fitech V5. We have seen the launch of our new web based system V5 which is based upon the original desktop system. The advantages of an online solution are clear to everyone and the uptake and/or upgrade to the online solution has been impressive. The diversity of companies using the system has reinforced our belief that online systems are now a fact of life and the future.  We’ve seen large corporations right through to individual personal trainers subscribe to our system. About us

In Australia and New Zealand, the promotion, support and development of the product will be shifted to the AU half of the technical team. Many customers may be unaware but our technical and support team is split between here, Reading, UK and Melbourne, Australia. This allows us to easily provide 24 hr support and upgrades.  Furthermore, the product now has a home in the Republic of South Africa and shortly in the United States. 2010 promises to be a big year for V5.

2009 has been a foundation and cornerstone for Fitech V5. We have implemented many new features along the way and will continue to do so into 2010. We have listed a few items below, which we will be tackling early on:

  • The Nutrition Module will be developed in 2010 and already some customers are helping us to design the module
  • Prochaska and DiClemente’s Stages of Change model
  • Tools for the consultant to manage their subjects
  • Incorporation of ‘bulk’ emailing
  • Improved Group Data Analysis Reporting
  • Short report
  • Improved functionality for Personal trainers & Improved Subject Access.
  • Easier ways to pay, Referral discounts
  • A Fitech Health & wellness Blog

Keep an eye out very early in the New Year for more information. If you are a existing client and have any requests please use the feedback form within V5.

If you are not using V5 or want to find out what all the fuss is about why not take our free 30 day trial.

Comments are closed.